Home/Filings/4/0001470831-25-000425
4//SEC Filing

Hallen Ed 4

Accession 0001470831-25-000425

CIK 0001835830other

Filed

Dec 16, 7:00 PM ET

Accepted

Dec 17, 5:19 PM ET

Size

8.3 KB

Accession

0001470831-25-000425

Insider Transaction Report

Form 4
Period: 2025-12-15
Hallen Ed
Director10% Owner
Transactions
  • Sale

    Series A Common Stock

    2025-12-15$30.13/sh157$4,730168,502 total(indirect: By Trust)
  • Sale

    Series A Common Stock

    2025-12-15$30.15/sh600$18,090607,918 total(indirect: By LLC)
Footnotes (5)
  • [F1]These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.024 to $30.155 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]Shares are owned directly by Hodgkins Trust for the benefit of the Reporting Person and the Reporting Person's family, and of which the trustee is an independent institution. The Reporting Person disclaims Section 16 beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.
  • [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.15 to $30.155 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F5]Shares held by Hodgkins LLC, of which the Reporting Person serves as manager. The Reporting Person disclaims Section 16 beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.

Issuer

Klaviyo, Inc.

CIK 0001835830

Entity typeother

Related Parties

1
  • filerCIK 0001991125

Filing Metadata

Form type
4
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 5:19 PM ET
Size
8.3 KB